
Neogen Corporation NEOG
$ 7.13
0.0%
Quarterly report 2025-Q3
added 10-09-2025
Neogen Corporation EV - Enterprise Value 2011-2025 | NEOG
Annual EV - Enterprise Value Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.26 B | 5.04 B | 5.76 B | 2.51 B | 3.89 B | 4.21 B | 3.26 B | 4.12 B | 2.62 B | 2.11 B | 1.74 B | 1.49 B | 1.32 B | 1.08 B | 1.04 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.76 B | 1.04 B | 2.83 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 19.37 | - | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 21.18 | - | $ 228 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.24 | - | $ 7.04 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.4 | - | $ 1.09 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 230.32 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.04 | - | $ 285 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.52 | - | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.57 | - | $ 18.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DexCom
DXCM
|
52.4 B | $ 67.57 | - | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.72 | - | $ 808 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 19.48 | - | $ 1.05 B | ||
|
Celcuity
CELC
|
506 M | $ 102.25 | - | $ 4.03 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.2 | - | $ 102 K | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 6.48 | - | $ 587 M | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 5.08 | - | $ 2.73 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 226.92 | - | $ 41.1 B | ||
|
National Research Corporation
NRC
|
1.08 B | $ 18.66 | - | $ 458 M | ||
|
Guardant Health
GH
|
6.94 B | $ 102.98 | - | $ 12.6 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
229 M | $ 8.14 | - | $ 482 M | ||
|
Quidel Corporation
QDEL
|
460 M | $ 29.3 | - | $ 1.23 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 45.37 | - | $ 10.1 B | ||
|
RadNet
RDNT
|
5.09 B | $ 73.15 | - | $ 5.34 B | ||
|
Illumina
ILMN
|
15.3 B | $ 134.95 | - | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 203.66 | - | $ 10.5 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 175.94 | - | $ 19.5 B | ||
|
Biodesix
BDSX
|
142 M | $ 6.82 | - | $ 884 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 253.89 | - | $ 21.3 B | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 580.74 | - | $ 222 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 182.84 | - | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 688.48 | - | $ 56.8 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.71 | - | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 420.1 | - | $ 30.1 B |